Skip to content

The effect of Achillea millefolium oral supplement on the delirium

The effect of Achillea millefolium oral supplement on the delirium in the intensive care unit patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131228015965N25
Enrollment
80
Registered
2024-11-29
Start date
2024-09-22
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium. Other delirium ( Postoperative delirium)

Interventions

Intervention 1: Intervention group:In the intervention group, patients receive an oral supplement dose of Yarrow capsule of 500 mg (the product includes the composition of Yarrow extract, microcrystal

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Consent of the patient or consent of the first degree of the patient to participate in the study Age 18-70 years of both sexes Family availability Not having a history of blindness and deafness Score 10-18 in SOFA criteria Insensitivity to herbal medicines Obtaining a score higher than 12 in the GCS criterion Absence of pregnancy No use of chemical drugs to treat delirium Absence of predetermined cognitive diseases such as: delirium, dementia, Alzheimer's, schizophrenia, loss of memory and attention. No alcohol consumption

Exclusion criteria

Exclusion criteria: Lack of consent to continue participating in the study Death or discharge of the patient before completion of the study Decreased level of consciousness and need for mechanical ventilation Not taking yarrow oral supplement or placebo for three consecutive days Allergy to herbal medicines (dermatitis)

Design outcomes

Primary

MeasureTime frame
The score of the CAM ICU questionnaire. Timepoint: Once every 24 hours. Method of measurement: CAM ICU questionnaire.

Secondary

MeasureTime frame
The amount of score received from the CAM ICU questionnaire. Timepoint: Once every 24 hours. Method of measurement: CAM ICU questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Kazemi

Rafsanjan University of Medical Sciences

dr.kazzemi.m@rums.ac.ir0097 3428 34

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026